Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData
Deal value decreased by 89 per cent in Jan 2021, compared to Dec 2020
In January 2021, the healthcare industry reported 70 deals worth $6.2 billion as compared to last 12-month average (January 2020 to December 2020) of 87 deals worth $17.1 billion.
Sanofi, a pharma company to acquire Kymab, a clinical-stage biopharma company focusing on developing fully human monoclonal antibody therapeutics for approximately $1.4 billion; Angelini Pharma, a pharma company to acquire Arvelle Therapeutics, a biopharma company for $960 million; Thermo Fisher Scientific, to acquire Henogen S.A., a biotech company for $880.8 million and Nordic Capital, to acquire Advanz Pharma Corp, a pharma company for $846 million were some of the major deals that contributed 66 per cent of the total deal value during January 2021.
Deal Date | Acquirer (s) | Target | Deal Value ($ m) |
11-Jan-21 | Sanofi (France) | Kymab Ltd (UK) | 1,450.0 |
4-Jan-21 | Angelini Spa (Italy) | Arvelle Therapeutics GmbH (Switzerland) | 960.0 |
15-Jan-21 | Thermo Fisher Scientific Inc (US) | Henogen S.A. (Belgium) | 880.8 |